BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 27013591)

  • 1. Predictive value of EGFR overexpression and gene amplification on icotinib efficacy in patients with advanced esophageal squamous cell carcinoma.
    Wang X; Niu H; Fan Q; Lu P; Ma C; Liu W; Liu Y; Li W; Hu S; Ling Y; Guo L; Ying J; Huang J
    Oncotarget; 2016 Apr; 7(17):24744-51. PubMed ID: 27013591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Icotinib in Patients with Pretreated Advanced Esophageal Squamous Cell Carcinoma with EGFR Overexpression or EGFR Gene Amplification: A Single-Arm, Multicenter Phase 2 Study.
    Huang J; Fan Q; Lu P; Ying J; Ma C; Liu W; Liu Y; Tan F; Sun Y
    J Thorac Oncol; 2016 Jun; 11(6):910-7. PubMed ID: 26980473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Icotinib With Concurrent Radiotherapy vs Radiotherapy Alone in Older Adults With Unresectable Esophageal Squamous Cell Carcinoma: A Phase II Randomized Clinical Trial.
    Luo H; Jiang W; Ma L; Chen P; Fang M; Ding L; Hua Y; Du D; Jing Z; Xie R; Song Y; Wang J; Zhou R; Tian Z; Wu S
    JAMA Netw Open; 2020 Oct; 3(10):e2019440. PubMed ID: 33026449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic value of EGFR overexpression and amplification in Esophageal squamous cell Carcinoma.
    Jiang D; Li X; Wang H; Shi Y; Xu C; Lu S; Huang J; Xu Y; Zeng H; Su J; Hou Y; Tan L
    BMC Cancer; 2015 May; 15():377. PubMed ID: 25953424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of icotinib in advanced lung squamous cell carcinoma.
    Liang S; Xu Y; Tan F; Ding L; Ma Y; Wang M
    Cancer Med; 2018 Sep; 7(9):4456-4466. PubMed ID: 30109777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of epidermal growth factor receptor overexpression with increased epidermal growth factor receptor gene copy number in esophageal squamous cell carcinomas.
    Yang YL; Xu KL; Zhou Y; Gao X; Chen LR
    Chin Med J (Engl); 2012 Feb; 125(3):450-4. PubMed ID: 22490401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene amplification of EGFR, HER2, FGFR2 and MET in esophageal squamous cell carcinoma.
    Kato H; Arao T; Matsumoto K; Fujita Y; Kimura H; Hayashi H; Nishiki K; Iwama M; Shiraishi O; Yasuda A; Shinkai M; Imano M; Imamoto H; Yasuda T; Okuno K; Shiozaki H; Nishio K
    Int J Oncol; 2013 Apr; 42(4):1151-8. PubMed ID: 23426935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrospective analysis of icotinib neoadjuvant therapy of 63 lung cancer patients.
    Wang T; Liu Y; Zhou B; Hao S; Wang Z; Liang N; Liu J; Wang S
    Indian J Cancer; 2017; 54(1):215-222. PubMed ID: 29199694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression and gene amplification of both ERBB2 and EGFR in an esophageal squamous cell carcinoma revealed by fluorescence in situ hybridization, multiplex ligation-dependent probe amplification and immunohistochemistry.
    Oyama T; Okamoto K; Nakamura R; Tajiri R; Ikeda H; Ninomiya I; Ooi A
    Pathol Int; 2015 Nov; 65(11):608-13. PubMed ID: 26314265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relation of EGFR expression by immunohistochemical staining and clinical response of combination treatment of nimotuzumab and chemotherapy in esophageal squamous cell carcinoma.
    Jia J; Cui Y; Lu M; Wang X; Li J; Li J; Li Y; Zhang X; Gao J; Zhou J; Lu Z; Gong J; Yu J; Sun Z; Liu C; Shen L; Zhang X
    Clin Transl Oncol; 2016 Jun; 18(6):592-8. PubMed ID: 26459251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct effects of EGFR inhibitors on epithelial- and mesenchymal-like esophageal squamous cell carcinoma cells.
    Yoshioka M; Ohashi S; Ida T; Nakai Y; Kikuchi O; Amanuma Y; Matsubara J; Yamada A; Miyamoto S; Natsuizaka M; Nakagawa H; Chiba T; Seno H; Muto M
    J Exp Clin Cancer Res; 2017 Aug; 36(1):101. PubMed ID: 28764725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Squamous cell carcinoma of the esophagus: evaluation of the status of epidermal growth factor receptors (EGFR and HER-2) by immunohistochemistry and in situ hybridization.
    Delektorskaya VV; Chemeris GY; Zavalishina LE; Ryazantseva AA; Grigorchuk AY; Kononets PV; Davydov MI
    Bull Exp Biol Med; 2010 Oct; 149(5):615-20. PubMed ID: 21165401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Icotinib: efficacy in different solid tumors and gene mutations.
    Zhao Q; Cheng J; Chen P; Sun J; Guan S
    Anticancer Drugs; 2020 Mar; 31(3):205-210. PubMed ID: 31934888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations in epidermal growth factor receptors 1 and 2 in esophageal squamous cell carcinomas.
    Gonzaga IM; Soares-Lima SC; de Santos PT; Blanco TC; de Reis BS; Quintella DC; de Oliveira IM; de Faria PA; Kruel CD; Andreollo NA; de Simão TA; Pinto LF
    BMC Cancer; 2012 Dec; 12():569. PubMed ID: 23207070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermal growth factor receptor overexpression/amplification in adenocarcinomas arising in the gastrointestinal tract.
    Rossi E; Villanacci V; Danesino C; Donato F; Nascimbeni R; Bassotti G
    Rev Esp Enferm Dig; 2011 Dec; 103(12):632-9. PubMed ID: 22217347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EGFR protein overexpression and gene amplification in squamous cell carcinomas of the esophagus.
    Hanawa M; Suzuki S; Dobashi Y; Yamane T; Kono K; Enomoto N; Ooi A
    Int J Cancer; 2006 Mar; 118(5):1173-80. PubMed ID: 16161046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic implications of
    Kwon D; Yun JY; Keam B; Kim YT; Jeon YK
    World J Gastroenterol; 2016 Nov; 22(44):9803-9812. PubMed ID: 27956804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EGFR Expression in Patients with Esophageal Squamous Cell Carcinoma and its Association with Pathologic Response to Preoperative Chemoradiotherapy: A Study in Northeastern Iran.
    Anvari K; Sima HR; Seilanian Toussi M; Anvari A; Shahidsales S; Memar B; Aledavoud SA; Forghani MN; Abdollahi A; Ghaffarzadegan K
    Arch Iran Med; 2017 Apr; 20(4):240-245. PubMed ID: 28412829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lapatinib inhibits the growth of esophageal squamous cell carcinoma and synergistically interacts with 5-fluorouracil in patient-derived xenograft models.
    Hou W; Qin X; Zhu X; Fei M; Liu P; Liu L; Moon H; Zhang P; Greshock J; Bachman KE; Ye BC; Wang H; Zang CY
    Oncol Rep; 2013 Aug; 30(2):707-14. PubMed ID: 23708506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of elevated ERK expression and its positive correlation with EGFR in Kazakh patients with esophageal squamous cell carcinoma.
    Cui X; Li S; Li T; Pang X; Zhang S; Jin J; Hu J; Liu C; Yang L; Peng H; Jiang J; Liang W; Suo J; Li F; Chen Y
    Int J Clin Exp Pathol; 2014; 7(5):2382-91. PubMed ID: 24966948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.